Oncology sponsored testing programs 

Invitae partners with biopharma companies to offer sponsored testing for patients who meet eligibility criteria

Detect Hereditary Pancreatic Cancer 

The Detect Hereditary Pancreatic Cancer program provides sponsored, no-charge genetic testing and counseling for individuals diagnosed with pancreatic cancer.

More than 56,000 adult Americans are diagnosed with pancreatic cancer annually and it is the fourth leading cause of cancer death among U.S. adults. The Detect Hereditary Pancreatic Cancer program is designed to identify patients with pancreatic cancer who may be eligible for precision therapies and surgical treatment options based on germline genetic test results.
 

Detect Hereditary Prostate Cancer

The Detect Hereditary Prostate Cancer genetic testing program provides sponsored, no-charge genetic testing and counseling for individuals diagnosed with prostate cancer stage II and above.

Prostate cancer is the leading cancer in males. An estimated 174,000 patients are newly diagnosed each year in the U.S. The Detect Hereditary Prostate Cancer program is designed to determine the germline genetic etiology of prostate cancer to evaluate precision medical and surgical treatment options.